Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease-Reference-Cited by-同舟云学术

Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease

Published:2022 Issue:31 Volume:10 Page:5853-5872
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Li De-feng¹,Yang Mei-feng²,Xu Hao-ming³,Zhu Min-zheng³^ORCID,Zhang Yuan⁴,Tian Cheng-mei⁵,Nie Yu-qiang³,Wang Jian-yao⁶,Liang Yu-jie⁷^ORCID,Yao Jun¹,Wang Li-sheng¹^ORCID

Affiliation:

1. Department of Gastroenterology, Shenzhen People's Hospital (the Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology), No. 1017, Dongmen North Road, Luohu District, Shenzhen 518020, Guangdong, China

2. Department of Hematology, Yantian District People's Hospital, Shenzhen 518020, Guangdong, China

3. Department of Gastroenterology and Hepatology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510030, China

4. Department of Medical Administration, Huizhou Institute of Occupational Diseases Control and Prevention, Huizhou 516000, Guangdong, China

5. Department of Emergency, Shenzhen People's Hospital (the Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong, China

6. Department of General Surgery, Shenzhen Children's Hospital, No. 7019, Yitian Road, Futian District, Shenzhen 518026, Guangdong, China

7. Shenzhen Kangning Hospital, No. 1080, Cuizu Road, Luohu District, Shenzhen 518020, Guangdong, China

Abstract

As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel disease (IBD) is characterized by recurrent intestinal mucosal inflammation.

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D2TB01190E

Reference214 articles.

1. Pathophysiology of Inflammatory Bowel Diseases

2. Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

3. New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing biomaterials for the treatment of autoimmune diseases;Applied Materials Today;2024-08

2. Residue‐Free Orally Administered Drug Carrier Based on a Porous Aromatic Framework for Efficient Multisite Treatment;Small;2024-07-17

3. The Role of Nanoparticle Morphology on Enhancing Delivery of Budesonide for Treatment of Inflammatory Bowel Disease;ACS Applied Materials & Interfaces;2024-06-18

4. Modern high-tech approaches to the diagnosis of gastrointestinal diseases;CARDIOMETRY;2024-05-25

5. Advances in the Interaction between Food-Derived Nanoparticles and the Intestinal Barrier;Journal of Agricultural and Food Chemistry;2024-02-12